{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:38:36Z","timestamp":1792813116061,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We explored the gut microbiota profile among HIV-infected individuals with diverse immune recovery profiles following long-term suppressive ART and investigated the relationship between the altered bacteria with markers of immune dysfunction. The microbiota profile of rectal swabs from 26 HIV-infected individuals and 20 HIV-uninfected controls were examined. Patients were classified as suboptimal responders, sIR (n\u2009=\u200910, CD4 T-cell\u2009&lt;350 cells\/ul) and optimal responders, oIR (n\u2009=\u200916, CD4 T-cell\u2009&gt;500 cells\/ul) after a minimum of 2 years on suppressive ART. Canonical correlation analysis(CCA) and multiple regression modelling were used to explore the association between fecal bacterial taxa abundance and immunological profiles in optimal and suboptimal responders. We found\n                    <jats:italic>Fusobacterium<\/jats:italic>\n                    was significantly enriched among the HIV-infected and the sIR group. CCA results showed that\n                    <jats:italic>Fusobacterium<\/jats:italic>\n                    abundance was negatively correlated with CD4 T-cell counts, but positively correlated with CD4 T-cell activation and CD4 Tregs. Multiple linear regression analysis adjusted for age, baseline CD4 T-cell count, antibiotic exposure and MSM status indicated that higher\n                    <jats:italic>Fusobacterium<\/jats:italic>\n                    relative abundance was independently\u00a0associated with poorer CD4 T-cell recovery following ART. Enrichment of\n                    <jats:italic>Fusobacterium<\/jats:italic>\n                    was associated with reduced immune recovery\u00a0and persistent immune dysfunction following ART. Modulating the abundance of this bacterial taxa in the gut may be a viable intervention to improve immune reconstitution in our setting.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-32585-x","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T09:31:06Z","timestamp":1537263066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals"],"prefix":"10.1038","volume":"8","author":[{"given":"Soo Ching","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling Ling","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Hwei","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung Fei","family":"Khang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Yoon","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Iskandar","family":"Raja Azwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeeba","family":"Kamarulzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Ling","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne Ai Lian","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u2019ng","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Rajasuriar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"32585_CR1","doi-asserted-by":"publisher","first-page":"11708","DOI":"10.1128\/JVI.77.21.11708-11717.2003","volume":"77","author":"M Guadalupe","year":"2003","unstructured":"Guadalupe, M. et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708\u201311717 (2003).","journal-title":"J. Virol."},{"key":"32585_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley, J. M. et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749\u2013759, https:\/\/doi.org\/10.1084\/jem.20040874 (2004).","journal-title":"J. Exp. Med."},{"key":"32585_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.20041196","volume":"200","author":"S Mehandru","year":"2004","unstructured":"Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med 200, 761\u2013770, https:\/\/doi.org\/10.1084\/jem.20041196 (2004).","journal-title":"J. Exp. Med"},{"key":"32585_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1128\/JVI.01739-06","volume":"81","author":"S Mehandru","year":"2007","unstructured":"Mehandru, S. et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 81, 599\u2013612, https:\/\/doi.org\/10.1128\/JVI.01739-06 (2007).","journal-title":"J. Virol."},{"key":"32585_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jaci.2005.05.040","volume":"116","author":"S Mehandru","year":"2005","unstructured":"Mehandru, S., Tenner-Racz, K., Racz, P. & Markowitz, M. The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection. J. Allergy Clin. Immunol. 116, 419\u2013422, https:\/\/doi.org\/10.1016\/j.jaci.2005.05.040 (2005).","journal-title":"J. Allergy Clin. Immunol."},{"key":"32585_CR6","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.4049\/jimmunol.1001801","volume":"185","author":"SN Gordon","year":"2010","unstructured":"Gordon, S. N. et al. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. J. Immunol. 185, 5169\u20135179, https:\/\/doi.org\/10.4049\/jimmunol.1001801 (2010).","journal-title":"J. Immunol."},{"key":"32585_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1086\/527324","volume":"197","author":"TW Chun","year":"2008","unstructured":"Chun, T. W. et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 197, 714\u2013720, https:\/\/doi.org\/10.1086\/527324 (2008).","journal-title":"J. Infect. Dis."},{"key":"32585_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1086\/656722","volume":"202","author":"SA Yukl","year":"2010","unstructured":"Yukl, S. A. et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J. Infect. Dis. 202, 1553\u20131561, https:\/\/doi.org\/10.1086\/656722 (2010).","journal-title":"J. Infect. Dis."},{"key":"32585_CR9","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1097\/QAD.0b013e32833ef7bb","volume":"24","author":"SA Yukl","year":"2010","unstructured":"Yukl, S. A. et al. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 24, 2451\u20132460, https:\/\/doi.org\/10.1097\/QAD.0b013e32833ef7bb (2010).","journal-title":"AIDS"},{"key":"32585_CR10","doi-asserted-by":"publisher","first-page":"e1006202","DOI":"10.1371\/journal.ppat.1006202","volume":"13","author":"E Maidji","year":"2017","unstructured":"Maidji, E., Somsouk, M., Rivera, J. M., Hunt, P. W. & Stoddart, C. A. Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction. PLoS Pathog. 13, e1006202, https:\/\/doi.org\/10.1371\/journal.ppat.1006202 (2017).","journal-title":"PLoS Pathog."},{"key":"32585_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIVinfection. Nat. Med. 12, 1365\u20131371, https:\/\/doi.org\/10.1038\/nm1511 (2006).","journal-title":"Nat. Med."},{"key":"32585_CR12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","volume":"203","author":"NG Sandler","year":"2011","unstructured":"Sandler, N. G. et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J. Infect. Dis. 203, 780\u2013790, https:\/\/doi.org\/10.1093\/infdis\/jiq118 (2011).","journal-title":"J. Infect. Dis."},{"key":"32585_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2217\/fmb-2016-0226","volume":"12","author":"S Serrano-Villar","year":"2017","unstructured":"Serrano-Villar, S., Ferrer, M., Gosalbes, M. J. & Moreno, S. How can the gut microbiota affect immune recovery in HIV-infected individuals? Future Microbiol. 12, 195\u2013199, https:\/\/doi.org\/10.2217\/fmb-2016-0226 (2017).","journal-title":"Future Microbiol."},{"key":"32585_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ebiom.2016.04.033","volume":"8","author":"S Serrano-Villar","year":"2016","unstructured":"Serrano-Villar, S. et al. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals. EBioMedicine 8, 203\u2013216, https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.033 (2016).","journal-title":"EBioMedicine"},{"key":"32585_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/mi.2014.107","volume":"8","author":"JF Vazquez-Castellanos","year":"2015","unstructured":"Vazquez-Castellanos, J. F. et al. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. Mucosal Immunol. 8, 760\u2013772, https:\/\/doi.org\/10.1038\/mi.2014.107 (2015).","journal-title":"Mucosal Immunol."},{"key":"32585_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2016.01.032","volume":"5","author":"M Noguera-Julian","year":"2016","unstructured":"Noguera-Julian, M. et al. Gut Microbiota Linked to Sexual Preference and HIV Infection. E Bio Medicine 5, 135\u2013146, https:\/\/doi.org\/10.1016\/j.ebiom.2016.01.032 (2016).","journal-title":"EBioMedicine"},{"key":"32585_CR17","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/QAD.0000000000000869","volume":"29","author":"P Nowak","year":"2015","unstructured":"Nowak, P. et al. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS 29, 2409\u20132418, https:\/\/doi.org\/10.1097\/QAD.0000000000000869 (2015).","journal-title":"AIDS"},{"key":"32585_CR18","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1097\/QAD.0b013e3283611816","volume":"27","author":"J Perez-Santiago","year":"2013","unstructured":"Perez-Santiago, J. et al. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS 27, 1921\u20131931 (2013).","journal-title":"AIDS"},{"key":"32585_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/mi.2013.116","volume":"7","author":"SM Dillon","year":"2014","unstructured":"Dillon, S. M. et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 7, 983\u2013994, https:\/\/doi.org\/10.1038\/mi.2013.116 (2014).","journal-title":"Mucosal Immunol."},{"key":"32585_CR20","doi-asserted-by":"publisher","first-page":"193ra191","DOI":"10.1126\/scitranslmed.3006438","volume":"5","author":"I Vujkovic-Cvijin","year":"2013","unstructured":"Vujkovic-Cvijin, I. et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5, 193ra191, https:\/\/doi.org\/10.1126\/scitranslmed.3006438 (2013).","journal-title":"Sci. Transl. Med."},{"key":"32585_CR21","doi-asserted-by":"publisher","first-page":"e1003829","DOI":"10.1371\/journal.ppat.1003829","volume":"10","author":"EA Mutlu","year":"2014","unstructured":"Mutlu, E. A. et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog. 10, e1003829, https:\/\/doi.org\/10.1371\/journal.ppat.1003829 (2014).","journal-title":"PLoS Pathog."},{"key":"32585_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/infdis\/jiu409","volume":"211","author":"DM Dinh","year":"2015","unstructured":"Dinh, D. M. et al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis. 211, 19\u201327, https:\/\/doi.org\/10.1093\/infdis\/jiu409 (2015).","journal-title":"J. Infect. Dis."},{"key":"32585_CR23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/mi.2011.15","volume":"4","author":"A Gori","year":"2011","unstructured":"Gori, A. et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the \u201cCOPA\u201d pilot randomized trial. Mucosal Immunol. 4, 554\u2013563, https:\/\/doi.org\/10.1038\/mi.2011.15 (2011).","journal-title":"Mucosal Immunol."},{"key":"32585_CR24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1172\/JCI66227","volume":"123","author":"NR Klatt","year":"2013","unstructured":"Klatt, N. R. et al. Probiotic\/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J. Clin. Invest. 123, 903\u2013907, https:\/\/doi.org\/10.1172\/JCI66227 (2013).","journal-title":"J. Clin. Invest."},{"key":"32585_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/QAI.0000000000000784","volume":"70","author":"B Stiksrud","year":"2015","unstructured":"Stiksrud, B. et al. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART. J. Acquir. Immune Defic. Syndr. 70, 329\u2013337, https:\/\/doi.org\/10.1097\/QAI.0000000000000784 (2015).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"32585_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3920\/BM2015.0163","volume":"7","author":"H Miller","year":"2016","unstructured":"Miller, H., Ferris, R. & Phelps, B. R. The effect of probiotics on CD4 counts among people living with HIV: a systematic review. Beneficial microbes 7, 345\u2013351, https:\/\/doi.org\/10.3920\/BM2015.0163 (2016).","journal-title":"Beneficial microbes"},{"issue":"5","key":"32585_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/19490976.2017.1334034","volume":"8","author":"Ivan Vujkovic-Cvijin","year":"2017","unstructured":"Vujkovic-Cvijin, I. et al. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. Gut microbes, 1\u201311, https:\/\/doi.org\/10.1080\/19490976.2017.1334034 (2017).","journal-title":"Gut Microbes"},{"key":"32585_CR28","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1128\/JVI.00099-16","volume":"90","author":"T Hensley-McBain","year":"2016","unstructured":"Hensley-McBain, T. et al. Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques. J. Virol. 90, 4981\u20134989, https:\/\/doi.org\/10.1128\/JVI.00099-16 (2016).","journal-title":"J. Virol."},{"key":"32585_CR29","doi-asserted-by":"publisher","first-page":"e0148952","DOI":"10.1371\/journal.pone.0148952","volume":"11","author":"GE Miller","year":"2016","unstructured":"Miller, G. E. et al. Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults. PLoS One 11, e0148952, https:\/\/doi.org\/10.1371\/journal.pone.0148952 (2016).","journal-title":"PLoS One"},{"key":"32585_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222\u2013227, https:\/\/doi.org\/10.1038\/nature11053 (2012).","journal-title":"Nature"},{"key":"32585_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.chom.2016.02.011","volume":"19","author":"CL Monaco","year":"2016","unstructured":"Monaco, C. L. et al. Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell Host Microbe 19, 311\u2013322, https:\/\/doi.org\/10.1016\/j.chom.2016.02.011 (2016).","journal-title":"Cell Host Microbe"},{"key":"32585_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.25","volume":"5","author":"Y Sun","year":"2016","unstructured":"Sun, Y. et al. Fecal bacterial microbiome diversity in chronic HIV-infected patients in China. Emerg Microbes Infect 5, e31, https:\/\/doi.org\/10.1038\/emi.2016.25 (2016).","journal-title":"Emerg Microbes Infect"},{"key":"32585_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/QAD.0000000000001409","volume":"31","author":"RG Nowak","year":"2017","unstructured":"Nowak, R. G. et al. Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria. AIDS 31, 857\u2013862, https:\/\/doi.org\/10.1097\/QAD.0000000000001409 (2017).","journal-title":"AIDS"},{"key":"32585_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.chom.2013.08.006","volume":"14","author":"CA Lozupone","year":"2013","unstructured":"Lozupone, C. A. et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 14, 329\u2013339, https:\/\/doi.org\/10.1016\/j.chom.2013.08.006 (2013).","journal-title":"Cell Host Microbe"},{"key":"32585_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-1-26","volume":"1","author":"IH McHardy","year":"2013","unstructured":"McHardy, I. H. et al. HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome 1, 26, https:\/\/doi.org\/10.1186\/2049-2618-1-26 (2013).","journal-title":"Microbiome"},{"key":"32585_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.micpath.2013.06.003","volume":"63","author":"JR Wu","year":"2013","unstructured":"Wu, J. R. et al. Mycoplasmas infection in male HIV\/AIDS patients in Jiangsu, China. Microb. Pathog. 63, 54\u201358, https:\/\/doi.org\/10.1016\/j.micpath.2013.06.003 (2013).","journal-title":"Microb. Pathog."},{"key":"32585_CR37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/QAD.0000000000000154","volume":"28","author":"G Yu","year":"2014","unstructured":"Yu, G., Fadrosh, D., Ma, B., Ravel, J. & Goedert, J. J. Anal microbiota profiles in HIV-positive and HIV-negative MSM. AIDS 28, 753\u2013760, https:\/\/doi.org\/10.1097\/QAD.0000000000000154 (2014).","journal-title":"AIDS"},{"key":"32585_CR38","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1097\/QAD.0b013e32833c93ce","volume":"24","author":"S Piconi","year":"2010","unstructured":"Piconi, S. et al. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. AIDS 24, 1991\u20132000, https:\/\/doi.org\/10.1097\/QAD.0b013e32833c93ce (2010).","journal-title":"AIDS"},{"key":"32585_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/apc.1999.13.369","volume":"13","author":"C Scully","year":"1999","unstructured":"Scully, C. et al. Periodontopathic bacteria in English HIV-seropositive persons. AIDS Patient Care STDS 13, 369\u2013374, https:\/\/doi.org\/10.1089\/apc.1999.13.369 (1999).","journal-title":"AIDS Patient Care STDS"},{"key":"32585_CR40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1128\/CVI.00009-10","volume":"17","author":"OA Gonzalez","year":"2010","unstructured":"Gonzalez, O. A., Li, M., Ebersole, J. L. & Huang, C. B. HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes\/macrophages. Clin. Vaccine Immunol. 17, 1417\u20131427, https:\/\/doi.org\/10.1128\/CVI.00009-10 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"32585_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10620-014-3316-y","volume":"60","author":"T Tahara","year":"2015","unstructured":"Tahara, T. et al. Fusobacterium detected in colonic biopsy and clinicopathological features of ulcerative colitis in Japan. Dig. Dis. Sci. 60, 205\u2013210, https:\/\/doi.org\/10.1007\/s10620-014-3316-y (2015).","journal-title":"Dig. Dis. Sci."},{"key":"32585_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3343\/alm.2016.36.4.387","volume":"36","author":"Y Lee","year":"2016","unstructured":"Lee, Y., Eun, C. S., Lee, A. R., Park, C. H. & Han, D. S. Fusobacterium Isolates Recovered From Colonic Biopsies of Inflammatory Bowel Disease Patients in Korea. Ann. Lab. Med. 36, 387\u2013389, https:\/\/doi.org\/10.3343\/alm.2016.36.4.387 (2016).","journal-title":"Ann. Lab. Med."},{"key":"32585_CR43","doi-asserted-by":"publisher","unstructured":"Tahara, T. et al. Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis. Oncotarget, https:\/\/doi.org\/10.18632\/oncotarget.18716 (2017).","DOI":"10.18632\/oncotarget.18716"},{"key":"32585_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gut.2009.191320","volume":"60","author":"A Swidsinski","year":"2011","unstructured":"Swidsinski, A. et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum\/necrophorum. Gut 60, 34\u201340, https:\/\/doi.org\/10.1136\/gut.2009.191320 (2011).","journal-title":"Gut"},{"key":"32585_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195\u2013206, https:\/\/doi.org\/10.1016\/j.chom.2013.07.012 (2013).","journal-title":"Cell Host Microbe"},{"key":"32585_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207\u2013215, https:\/\/doi.org\/10.1016\/j.chom.2013.07.007 (2013).","journal-title":"Cell Host Microbe"},{"key":"32585_CR47","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00018-012-0936-2","volume":"69","author":"K Imai","year":"2012","unstructured":"Imai, K., Yamada, K., Tamura, M., Ochiai, K. & Okamoto, T. Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria. Cell. Mol. Life Sci. 69, 2583\u20132592, https:\/\/doi.org\/10.1007\/s00018-012-0936-2 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"32585_CR48","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/IAI.68.4.1893-1898.2000","volume":"68","author":"A Jewett","year":"2000","unstructured":"Jewett, A. et al. Induction of apoptotic cell death in peripheral blood mononuclear and polymorphonuclear cells by an oral bacterium, Fusobacterium nucleatum. Infect. Immun. 68, 1893\u20131898 (2000).","journal-title":"Infect. Immun."},{"key":"32585_CR49","doi-asserted-by":"publisher","first-page":"11422","DOI":"10.1128\/JVI.05608-11","volume":"85","author":"JM Shaw","year":"2011","unstructured":"Shaw, J. M. et al. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J. Virol. 85, 11422\u201311434, https:\/\/doi.org\/10.1128\/JVI.05608-11 (2011).","journal-title":"J. Virol."},{"key":"32585_CR50","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/infdis\/jis230","volume":"205","author":"G Mendez-Lagares","year":"2012","unstructured":"Mendez-Lagares, G. et al. Severe immune dysregulation affects CD4(+)CD25(hi)FoxP3(+) regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy. J. Infect. Dis. 205, 1501\u20131509, https:\/\/doi.org\/10.1093\/infdis\/jis230 (2012).","journal-title":"J. Infect. Dis."},{"key":"32585_CR51","doi-asserted-by":"publisher","first-page":"32ra36","DOI":"10.1126\/scitranslmed.3000632","volume":"2","author":"D Favre","year":"2010","unstructured":"Favre, D. et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2, 32ra36, https:\/\/doi.org\/10.1126\/scitranslmed.3000632 (2010).","journal-title":"Sci. Transl. Med."},{"key":"32585_CR52","doi-asserted-by":"publisher","first-page":"e0186000","DOI":"10.1371\/journal.pone.0186000","volume":"12","author":"SH Yap","year":"2017","unstructured":"Yap, S. H. et al. HIV\/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. PLoS One 12, e0186000, https:\/\/doi.org\/10.1371\/journal.pone.0186000 (2017).","journal-title":"PLoS One"},{"key":"32585_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/hiv.12432","volume":"18","author":"CY Leng","year":"2017","unstructured":"Leng, C. Y. et al. Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy. HIV Med. 18, 321\u2013331, https:\/\/doi.org\/10.1111\/hiv.12432 (2017).","journal-title":"HIV Med."},{"issue":"Suppl 1","key":"32585_CR54","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1073\/pnas.1000080107","volume":"108","author":"JG Caporaso","year":"2011","unstructured":"Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 108(Suppl 1), 4516\u20134522, https:\/\/doi.org\/10.1073\/pnas.1000080107 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"32585_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0250-1","volume":"5","author":"LL Chua","year":"2017","unstructured":"Chua, L. L. et al. Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome 5, 35, https:\/\/doi.org\/10.1186\/s40168-017-0250-1 (2017).","journal-title":"Microbiome"},{"key":"32585_CR56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335\u2013336, https:\/\/doi.org\/10.1038\/nmeth.f.303 (2010).","journal-title":"Nat Methods"},{"key":"32585_CR57","doi-asserted-by":"publisher","first-page":"e4600","DOI":"10.7717\/peerj.4600","volume":"6","author":"Li Chen","year":"2018","unstructured":"Chen, L. et al. GMPR: A robust normalization method for zero-inflated count data with application to microbiome sequencing data. Peer J. 6, e4600, https:\/\/doi.org\/10.7717\/peerj.4600. eCollection (2018).","journal-title":"PeerJ"},{"key":"32585_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60, https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60 (2011).","journal-title":"Genome Biol."},{"key":"32585_CR59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met 57, 289\u2013300 (1995).","journal-title":"J Roy Stat Soc B Met"},{"key":"32585_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0391-6","volume":"13","author":"R Rajasuriar","year":"2015","unstructured":"Rajasuriar, R. et al. The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte\/macrophage activation in treated HIV-infected individuals. J. Transl. Med. 13, 30, https:\/\/doi.org\/10.1186\/s12967-015-0391-6 (2015).","journal-title":"J. Transl. Med."},{"key":"32585_CR61","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.4155\/bio.13.74","volume":"5","author":"Y Huang","year":"2013","unstructured":"Huang, Y. et al. A simple LC-MS\/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients. Bioanalysis 5, 1397\u20131407, https:\/\/doi.org\/10.4155\/bio.13.74 (2013).","journal-title":"Bioanalysis"},{"key":"32585_CR62","unstructured":"Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32585-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:07:58Z","timestamp":1720602478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32585-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32585"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32585-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14277"}}